Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.6 USD | -1.37% | -10.89% | +18.03% |
05-14 | Atea Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-14 | Transcript : Atea Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.03% | 307M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- Atea Pharmaceuticals : JP Morgan Adjusts Price Target on Atea Pharmaceuticals to $66 From $45, Maintains Overweight Rating